ERAN BROSHY

Insider Reports History

Location
Somerset, NJ
Signature
/s/ Corinna Liebowitz, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by ERAN BROSHY:

Company Role Class Num Shares Value Price $ Report Date Ownership
Theravance Biopharma, Inc. Director Ordinary Shares 44,703 $894,060 $20.00 26 Nov 2025 Direct
Theravance Biopharma, Inc. Director Share Option (Right to Buy) 81,749 $829,752 $10.15 26 Nov 2025 Direct
Certara, Inc. Director, Chairman Common Stock 34,951 $485,469 $13.89 21 May 2025 Direct
Certara, Inc. Director, Chairman Restricted Stock Units 15,757 $211,961 $17.77 21 May 2025 Direct

Insider Reports Filed by ERAN BROSHY

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TBPH Theravance Biopharma, Inc. 26 Nov 2025 3 -$447,920 4 Director 01 Dec 2025, 19:02
TBPH Theravance Biopharma, Inc. 11 Nov 2025 4 -$667,150 4/A Director 14 Nov 2025, 06:00
CERT Certara, Inc. 21 May 2025 3 $0 4 Director, Chairman 22 May 2025, 16:58
TBPH Theravance Biopharma, Inc. 19 May 2025 2 $0 4 Director 21 May 2025, 19:02
CERT Certara, Inc. 21 May 2024 3 $0 4 Director 23 May 2024, 16:17
TBPH Theravance Biopharma, Inc. 08 May 2024 2 $0 4 Director 10 May 2024, 18:02
CERT Certara, Inc. 21 Aug 2023 2 +$79,058 4 Director 23 Aug 2023, 17:38
CERT Certara, Inc. 23 May 2023 3 $0 4 Director 25 May 2023, 08:50
TBPH Theravance Biopharma, Inc. 02 May 2023 2 $0 4 Director 04 May 2023, 18:36
CERT Certara, Inc. 13 Jul 2022 1 $0 4 Director 15 Jul 2022, 16:35
CERT Certara, Inc. 11 Jul 2022 0 $0 3 Director 15 Jul 2022, 16:26
TBPH Theravance Biopharma, Inc. 26 Apr 2022 2 $0 4 Director 28 Apr 2022, 20:54